Medical Research
Phelan Mcdermid Syndrome Foundation
OSPREY, FL
Total revenue
$1.3M
Total expenses
$1.4M
Net assets
$1.9M
Grants received
$1.0M
73 grants
EIN
043673104
Tax year
2024
Mission
The mission of the Phelan-McDermid Syndrome Foundation is to make today better and the future brighter for everyone living with Phelan-McDermid syndrome - from the moment of diagnosis to the delivery of treatments and cures.
Programs
2 programs
CARE program: The organization is committed to recruiting, educating, and ensuring a robust network of physicians and clinicians (who are familiar with and educated about the unique aspects of the multidisciplinary care needs involved with Phelan-McDermid syndrome) are available to families. The organization continues to create and provide multimedia materials to enhance understanding and educate healthcare professionals. To strengthen an expert clinical network for Phelan McDermid syndrome, the organization works to 1)share and discuss research and medical findings, exchange information and insights about the lived experience 2)promote better coordination of care through evidence-based information and translate research and innovation into clinical care 3) raise awareness with healthcare professionals and families to ensure patients get the right diagnosis faster and connect to the available information and resources 4)build a medical expertise network to enhance the quality and coordination of care.
CURE program (formerly research support): The organization works to facilitate research and data collection to advance treatments and cures by 1) centering patients and their families in conversations about external research studies and organization funding programs 2) attracting clinical studies and preparing families to participate in those studies 3) enabling coordinated and collaborative research and data collection to facilitate the monitoring and cross cutting knowledge of rare disorders which informs care management, treatments and health system planning 4) targeting increased participation in the PMSF DataHub which in turn can be marketed to science, research, and pharmaceutical companies.
Financials
FY 2024
Revenue
Expenses
People
10 listed
Rhonda Blumenthal
Chief Executive Officer
$122K
40 hrs/wk
Denise Croden
President
—
5 hrs/wk
Ben Holocher
Vice President
—
5 hrs/wk
Lisa Brown
Secretary
—
5 hrs/wk
Michael Cento
Treasurer
—
5 hrs/wk
Catherine Valcourt-Pearce
Director
—
5 hrs/wk
Chardell Buchanan
Director
—
5 hrs/wk
Eden Rivera
Director
—
5 hrs/wk
Dr Lori Levi
Director
—
5 hrs/wk
Heidi Grabenstatter PhD
Director
—
5 hrs/wk
Grants received
Showing 73 of 73
Funded by
$1.0M from 34 funders · 73 grants · 2017–2024
$204K · 3 grants · 2019–2023
$200K · 2 grants · 2023–2024
$94K · 7 grants · 2017–2023
$77K · 6 grants · 2019–2024
$75K · 3 grants · 2020–2024
$75K · 2 grants · 2023–2024
$58K · 4 grants · 2017–2023
$54K · 1 grant · 2018